Glenmark gets USFDA approval for generic Endometrin vaginal inserts
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Subscribe To Our Newsletter & Stay Updated